an industry perspective on access & benefit sharing tom jacob, senior advisor - global affairs,...
TRANSCRIPT
An Industry Perspective on Access & Benefit Sharing
Tom Jacob,
Senior Advisor - Global Affairs, DuPont
Chair, ICC Task Force on ABS
WTO
26 May 2004
The CBD Context CBD is dealing with legitimate issues
– But range of potential issues is vast Those issues go well beyond environmental concerns
– But, as MEA, many countries delegate to environment ministries
Role of indigenous/local communities is huge– But very ill-defined
Broad support among nations– But non-environment matters deliberated by
environment-focused delegates creates potential for “venue shopping”
ABS From Our Perspective… There is reason to hope for sustainable development
benefits– Direct linkage of resources to in-country stakeholders,
with expectation of benefits– Recognition of the linkages of development to
ecological and social/cultural impacts Nowhere are the agendas more complex
– New obligations for countries --> new obligations for industry
– We’re all trying to figure this out We need time and country-level
experience to find the right balance– Few countries with experience with ABS or
PIC regulations
A New CBD ABS Negotiation
Should be encouraging new regimes and experience, using Bonn Guidelines, but…
We now have new, broad negotiating mandate– Everything is on the table– Lock-in decisions with limited experience?
Danger to parallel processes– FAO International Treaty– WIPO Committee– WTO TRIPS Council
Conceptual Model of CBD ABSIn-situ Resource
BioprospectingConsultation w. Sovereign State
Consultation w. Indigenous/Local Communities
Mutually Agreed Terms/PIC
Ex-situ R&D
Development of Commercial Product
Patenting of Commercial Product
Sharing or Proceeds per MAT
Pursuant to National Regime
Complication: No National Regime
In-situ Resource
BioprospectingConsultation w. Sovereign State
Consultation w. Indigenous/Local Communities
Mutually Agreed Terms/PIC
Ex-situ R&D
Development of Commercial Product
Patenting of Commercial Product
Sharing or Proceeds per MAT
Pursuant to National Regime
?
?
Complication: Pre-CBD Extraction
In-situ Resource
BioprospectingConsultation w. Sovereign State
Consultation w. Indigenous/Local Communities
Mutually Agreed Terms/PIC
Ex-situ R&D
Development of Commercial Product
Patenting of Commercial Product
Sharing or Proceeds per MAT
Pursuant to National Regime
?
?
Complication: Pre-CBD w. “Country of Origin”
In-situ Resource
BioprospectingConsultation w. Sovereign State
Consultation w. Indigenous/Local Communities
Mutually Agreed Terms/PIC
Ex-situ R&D
Development of Commercial Product
Patenting of Commercial Product
Sharing or Proceeds per MAT
Pursuant to National Regime
?
Complications: Non-Patent GRUse – Patent-Linked System
In-situ Resource
BioprospectingConsultation w. Sovereign State
Consultation w. Indigenous/Local Communities
Mutually Agreed Terms/PIC
Ex-situ R&D
Development of Commercial Product
Patenting of Commercial Product
Sharing or Proceeds per MAT
Pursuant to National Regime
?
?
Complications: Burden of Transaction Costs
In-situ Resource
BioprospectingConsultation w. Sovereign State
Consultation w. Indigenous/Local Communities
Mutually Agreed Terms/PIC
Ex-situ R&D
Development of Commercial Product
Patenting of Commercial Product
Sharing or Proceeds per MAT
Pursuant to National RegimeExpected
Value of GR
Complications: Lower Expected Value
In-situ Resource
BioprospectingConsultation w. Sovereign State
Consultation w. Indigenous/Local Communities
Mutually Agreed Terms/PIC
Ex-situ R&D
Development of Commercial Product
Patenting of Commercial Product
Sharing or Proceeds per MAT
Pursuant to National RegimeExpected
Value of GR
Differing Perceptions of Value? Reference case for many is “blockbuster” drug discovery
from natural GR– Dependence of pharma on natural GR
Increased reliance upon new technologies for “drug design”– Less dependence upon natural GRs– Many major pharma firms reducing or
eliminating natural product research Remaining industries less likely to have
“blockbuster” yields– Plant breeding, agrochemicals, flavours & fragrances,
industrial enzymes, herbals, etc.
Challenges Shaping ABS Evolution
Country ABS regimes– Bonn Guidelines + learn from our experience
FAO Standardized MTA– A useful model?
Disclosure of PIC/Origin proposals– Limited coverage and legal complications
Certificate of Origin/Source/Legal Provinance proposals– Workable or will it collapse of own
weight?
Traditional Knowledge and Indigenous & Local Communities obligations– TK very complex IPR challenge
– Countries must sort this out consultative relations
Codes of Conduct among Commercial, Public and Non-Profit Institutions– Important, but too few as yet
Challenges Shaping ABS Evolution
Bye, Now...
Negotiating Boundary Conditions
Trading system– Evolved over hundreds of years
“Environmental” system– Evolved in past several decades– Not yet institutionalized– Quite undisciplined
Convention on Biological Diversity (CBD)
An environmental treaty…– Biological diversity, ecosystem integrity
But also an economic/social treaty– rights to genetic resources and traditional knowledge– rights of indigenous and local communities– equity concerns, and sharing of benefits
There is reason to hope for sustainable development benefits– Direct linkage of resources to in-country stakeholders, with
expectation of benefits– Recognition of the linkages of development to
ecological and social/cultural impacts
Bonn Guidelines -- A Major Step A broad “inventory” of potential measures and
ideas– Workable if used selectively
Needed: Countries to gain experience implementing regimes– Few countries with experience with ABS
or PIC regulations
– Need experience to learn implications of potential elements of ABS regimes
Should be encouraging new regimes and experience, using Bonn Guidelines
Complication: Exemption for Academic Research
In-situ Resource
BioprospectingConsultation w. Sovereign State
Consultation w. Indigenous/Local Communities
Mutually Agreed Terms/PIC
Ex-situ R&D
Development of Commercial Product
Patenting of Commercial Product
Sharing or Proceeds per MAT
Pursuant to National Regime
In-situ Resource
BioprospectingConsultation w. Sovereign State
Consultation w. Indigenous/Local Communities
Mutually Agreed Terms/PIC
Ex-situ R&D
Development of Commercial Product
Patenting of Commercial Product
Sharing or Proceeds per MAT
Pursuant to National Regime
Complication: Exemption for Academic ResearchProducts